Designing Studies to Find Early Signals of Efficacy

REFERENCES

• Bornkamp , B. , Bretz , F. , Dmitrienko , A. , Enas , G. , Gaydos , B. , Hsu , C.-H. , König , F. , Krams , M. , Liu , Q. , Neuenschwander , B. , Parke , T. , Pinheiro , J. , Roy , A. , Sax , R. , Shen , F. ( 2007 ). Innovative approaches for designing and analyzing adaptive dose-ranging trials . Journal of Biopharmaceutical Statistics 17 : 965 – 995 .
   PubMed Web of Science ®Google Scholar
• Bretz , F. , Schmidli , H. , König , F. , Racine , A. , Maurer , W. ( 2006 ). Confirmatory SEAMLESS Phase II/iii clinical trials with hypotheses selection at interim: General concepts . Biometrical Journal 48 ( 4 ): 623 – 634 .
   PubMed Web of Science ®Google Scholar
• Burman , C. F. , Grieve , A. P. , Senn , S. ( 2007 ). Decision analysis in drug development . In: Dmitrienko , A. , Chuang-Stein , C. , Agostino , R. , eds. Pharmaceutical Statistics Using SAS: A Practical Guide . Cary , NC : SAS Institute , pp. 385 – 428 .
   Google Scholar
• Chow , S. C. , Shao , J. , Wang , H. ( 2008 ). Sample Size Calculations in Clinical Research . Boca Raton , FL : Chapman & Hall/CRC .
   Google Scholar
• De Groot , M. ( 2004 ). Optimal Statistical Decisions . London , UK : Wiley, London .
   Google Scholar
• Emerson , J. D. , Tritchler , D. ( 1987 ). The three-decision problem in medical decision making . Statistics in Medicine 6 : 101 – 112 .
   PubMed Web of Science ®Google Scholar
• Fleming , T. R. ( 1982 ). One-sample multiple testing procedures for Phase II clinical trials . Biometrics 38 : 143 – 151 .
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration . ( 2004 ). Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. Challenges and Opportunities Report. Available at: http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm
   Google Scholar
• Gallo , P. , Chuang-Stein , C. , Dragalin , V. , Gaydos , B. , Krams , M. , Pinheiro , J. ( 2006 ). Adaptive designs in clinical drug development . Journal of Biopharmaceutical Statistics 16 : 275 – 283 .
   PubMed Web of Science ®Google Scholar
• Gaydos , B. , Anderson , K. , Berry , D. , Burnham , N. , Chuang-Stein , C. , Dudinak , J. , Fardipour , P. , Gallo , P. , Givens , S. , Lewis , R. , Maca , J. , Pinheiro , J. , Yili Pritchett , Y. , Krams , M. ( 2009 ). Good practices for adaptive clinical trials in pharmaceutical product development . Drug Information Journal 43 ( 5 ): 539 – 556 .
   Web of Science ®Google Scholar
• Hong , S. , Wang , Y. ( 2007 ). A three-outcome design for randomized comparative phase II clinical trials . Statistics in Medicine 26 : 3525 – 3534 .
   PubMed Web of Science ®Google Scholar
• Jennison , C. , Turnbull , B. ( 2000 ). Group Sequential Methods with Application to Clinical Trials . Boca Raton , FL : Chapman and Hall/CRC .
   Google Scholar
• Julious , S. A. , Swank , D. J. ( 2005 ). Moving statistics beyond the individual clinical trial: Applying decision science to optimize a clinical development plan . Pharmaceutical Statistics 4 ( 1 ): 37 – 46 .
   Web of Science ®Google Scholar
• PricewaterhouseCoopers . ( 2007 ). Pharma 2020: The vision: Which path will you take? Pharma 2020 series. Published online by PricewaterhouseCoopers. Available at: http://www.pwc.com/gx/en/pharma-life-sciences/pharma-2020/pharma-2020-vision-path.jhtml
   Google Scholar
• Rubinstein , L. V. , Korn , E. L. , Freidlin , B. , Hunsberger , S. , Ivy , S. P. , Smith , M. A. ( 2005 ). Design issues of randomized Phase II trials and a proposal for Phase II screening trials . Journal of Clinical Oncology 23 : 7199 – 7206 .
   PubMed Web of Science ®Google Scholar
• Sargent , D. J. , Chan , V. , Goldberg , R. M. ( 2001 ). A three-outcome design for Phase II clinical trials . Controlled Clinical Trials 22 : 117 – 125 .
   PubMedGoogle Scholar
• Shuster , J. ( 2002 ). Optimal two-stage designs for single arm Phase II cancer trials . Journal of Biopharmaceutical Statistics 12 ( 1 ): 39 – 51 .
   PubMedGoogle Scholar
• Storer , B. E. ( 1992 ). A class of Phase II designs with three possible outcomes . Biometrics 48 : 55 – 60 .
   PubMed Web of Science ®Google Scholar
• Thall , P. F. , Simon , R. M. , Estey , E. H. ( 1995 ). Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes . Statistics in Medicine 14 : 357 – 379 .
   PubMed Web of Science ®Google Scholar
• Wu , M. , Littman , G. , Dragalin , V. , Fardipour , P. , Krams , M. , Padmanabhan , K. S. , Nelson , R. , Sharma , A. , Hoseyni , C. Submitted for publication. LPDAT: A tool to facilitate decision-making for learn phase clinical trials. Pharmaceutical Statistics.
   Google Scholar